The prevalence of childhood obesity is increasing worldwide, along with the associated
common comorbidities of type 2 diabetes and cardiovascular disease in later life. Motivated …

Purpose A healthy diet reduces the risk of non-alcoholic fatty liver disease (NAFLD) in the
general population, especially in individuals who are genetically predisposed to NAFLD …

Background Non-alcoholic fatty liver disease (NAFLD) has emerged as a predominant driver
of chronic liver disease globally and is associated with increased cardiovascular disease …

Abstract Background & Aims Genome‐wide association studies have identified steatogenic
variants that also showed pleiotropic effects on cardiometabolic traits in adults. We …

Simple Summary This review mainly focuses on epigenetic changes in a few selective
genes associated with insulin insensitivity in the periphery and how this peripheral insulin …

Genome-wide association studies (GWAS) are often performed on ratios composed of a
numerator trait divided by a denominator trait. Examples include body mass index (BMI) and …

Background: Fibrosis-4 (FIB4) is a recommended noninvasive test to assess hepatic fibrosis
among patients with metabolic dysfunction–associated steatotic liver disease (MASLD) …

Metabolic dysfunction-associated fatty liver disease (MAFLD) is the most common liver
disease worldwide. The risk of developing MAFLD varies among individuals, due to a …

Background This study aimed to investigate the relationship of residential green and blue
spaces with incident nonalcoholic fatty liver disease (NAFLD), and explore the potential …

Background The underlying mechanisms for the link between steatotic liver disease and
cardiovascular and cancer outcomes are poorly understood. We aimed to use MRI-derived …